Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Functional genetic variation in the Rev-Erbα pathway and lithium response in the treatment of bipolar disorder.

McCarthy MJ, Nievergelt CM, Shekhtman T, Kripke DF, Welsh DK, Kelsoe JR.

Genes Brain Behav. 2011 Nov;10(8):852-61. doi: 10.1111/j.1601-183X.2011.00725.x. Epub 2011 Sep 2.

2.

Genetic and clinical factors predict lithium's effects on PER2 gene expression rhythms in cells from bipolar disorder patients.

McCarthy MJ, Wei H, Marnoy Z, Darvish RM, McPhie DL, Cohen BM, Welsh DK.

Transl Psychiatry. 2013 Oct 22;3:e318. doi: 10.1038/tp.2013.90.

3.

Associations between polymorphisms in the NR1D1 gene encoding for nuclear receptor REV-ERBα and circadian typologies.

Kang JI, Park CI, Namkoong K, Kim SJ.

Chronobiol Int. 2015 May;32(4):568-72. doi: 10.3109/07420528.2015.1006327. Epub 2015 Mar 23.

PMID:
25798852
4.

Nuclear receptor Rev-erbalpha is a critical lithium-sensitive component of the circadian clock.

Yin L, Wang J, Klein PS, Lazar MA.

Science. 2006 Feb 17;311(5763):1002-5.

5.

Glycogen synthase kinase 3β gene polymorphisms may be associated with bipolar I disorder and the therapeutic response to lithium.

Lin YF, Huang MC, Liu HC.

J Affect Disord. 2013 May;147(1-3):401-6. doi: 10.1016/j.jad.2012.08.025. Epub 2012 Sep 27.

PMID:
23021822
6.

Polymorphism of circadian clock genes and prophylactic lithium response.

Rybakowski JK, Dmitrzak-Weglar M, Kliwicki S, Hauser J.

Bipolar Disord. 2014 Mar;16(2):151-8.

PMID:
24636202
7.

Association study of the glycogen synthase kinase-3beta gene polymorphism with prophylactic lithium response in bipolar patients.

Szczepankiewicz A, Rybakowski JK, Suwalska A, Skibinska M, Leszczynska-Rodziewicz A, Dmitrzak-Weglarz M, Czerski PM, Hauser J.

World J Biol Psychiatry. 2006;7(3):158-61.

PMID:
16861141
8.

Nuclear receptor rev-erb-{alpha} circadian gene variants and lithium carbonate prophylaxis in bipolar affective disorder.

Campos-de-Sousa S, Guindalini C, Tondo L, Munro J, Osborne S, Floris G, Pedrazzoli M, Tufik S, Breen G, Collier D.

J Biol Rhythms. 2010 Apr;25(2):132-7. doi: 10.1177/0748730410362713.

PMID:
20348464
9.

Association study of the INPP1, 5HTT, BDNF, AP-2beta and GSK-3beta GENE variants and restrospectively scored response to lithium prophylaxis in bipolar disorder.

Michelon L, Meira-Lima I, Cordeiro Q, Miguita K, Breen G, Collier D, Vallada H.

Neurosci Lett. 2006 Aug 7;403(3):288-93. Epub 2006 Jun 19.

PMID:
16787706
10.

Mice lacking circadian clock components display different mood-related behaviors and do not respond uniformly to chronic lithium treatment.

Schnell A, Sandrelli F, Ranc V, Ripperger JA, Brai E, Alberi L, Rainer G, Albrecht U.

Chronobiol Int. 2015;32(8):1075-89. doi: 10.3109/07420528.2015.1062024. Epub 2015 Aug 28.

PMID:
26317159
11.

A circadian clock gene, Rev-erbα, modulates the inflammatory function of macrophages through the negative regulation of Ccl2 expression.

Sato S, Sakurai T, Ogasawara J, Takahashi M, Izawa T, Imaizumi K, Taniguchi N, Ohno H, Kizaki T.

J Immunol. 2014 Jan 1;192(1):407-17. doi: 10.4049/jimmunol.1301982. Epub 2013 Dec 4.

12.

DBC1 (Deleted in Breast Cancer 1) modulates the stability and function of the nuclear receptor Rev-erbα.

Chini CC, Escande C, Nin V, Chini EN.

Biochem J. 2013 May 1;451(3):453-61. doi: 10.1042/BJ20121085.

13.

Association study in a Sardinian sample between bipolar disorder and the nuclear receptor REV-ERBalpha gene, a critical component of the circadian clock system.

Severino G, Manchia M, Contu P, Squassina A, Lampus S, Ardau R, Chillotti C, Del Zompo M.

Bipolar Disord. 2009 Mar;11(2):215-20. doi: 10.1111/j.1399-5618.2009.00667.x.

PMID:
19267705
14.

Identification of a novel circadian clock modulator controlling BMAL1 expression through a ROR/REV-ERB-response element-dependent mechanism.

Lee J, Lee S, Chung S, Park N, Son GH, An H, Jang J, Chang DJ, Suh YG, Kim K.

Biochem Biophys Res Commun. 2016 Jan 15;469(3):580-6. doi: 10.1016/j.bbrc.2015.12.030. Epub 2015 Dec 12.

15.

The effect of dexamethasone on clock gene mRNA levels in bovine neutrophils and lymphocytes.

Nebzydoski SJ, Pozzo S, Nemec L, Rankin MK, Gressley TF.

Vet Immunol Immunopathol. 2010 Dec 1;138(3):183-92. doi: 10.1016/j.vetimm.2010.07.017. Epub 2010 Aug 10.

PMID:
20807668
16.

Lithium increases platelet serine-9 phosphorylated GSK-3β levels in drug-free bipolar disorder during depressive episodes.

de Sousa RT, Zanetti MV, Talib LL, Serpa MH, Chaim TM, Carvalho AF, Brunoni AR, Busatto GF, Gattaz WF, Machado-Vieira R.

J Psychiatr Res. 2015 Mar;62:78-83. doi: 10.1016/j.jpsychires.2015.01.016. Epub 2015 Feb 7.

PMID:
25691093
17.

Glucocorticoid receptor polymorphism is associated with lithium response in bipolar patients.

Szczepankiewicz A, Rybakowski JK, Suwalska A, Hauser J.

Neuro Endocrinol Lett. 2011;32(4):545-51.

PMID:
21876507
18.

Interacting genes in lithium prophylaxis: preliminary results of an exploratory analysis on the role of DGKH and NR1D1 gene polymorphisms in 199 Sardinian bipolar patients.

Manchia M, Squassina A, Congiu D, Chillotti C, Ardau R, Severino G, Del Zompo M.

Neurosci Lett. 2009 Dec 25;467(2):67-71. doi: 10.1016/j.neulet.2009.10.003. Epub 2009 Oct 7.

PMID:
19818381
19.

Lithium differentially affects clock gene expression in serum-shocked NIH-3T3 cells.

Osland TM, Fernø J, Håvik B, Heuch I, Ruoff P, Lærum OD, Steen VM.

J Psychopharmacol. 2011 Jul;25(7):924-33. doi: 10.1177/0269881110379508. Epub 2010 Sep 13.

PMID:
20837565
20.

The association study of three FYN polymorphisms with prophylactic lithium response in bipolar patients.

Szczepankiewicz A, Skibinska M, Suwalska A, Hauser J, Rybakowski JK.

Hum Psychopharmacol. 2009 Jun;24(4):287-91. doi: 10.1002/hup.1018.

PMID:
19330793

Supplemental Content

Support Center